Renal function trajectories in patients with prior improved EGFR slopes and risk of death

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Xie, Yan ^a   Bowe, Benjamin ^a   Xian, Hong ^a,b   Balasubramanian, Sumitra ^a   Al Aly, Ziyad ^a  

^a VA St Louis Healthcare System   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CHRONIC LUNG DISEASE; DEATH; DEMENTIA; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHENOTYPE; RISK ASSESSMENT; WEIGHT REDUCTION; CHRONIC KIDNEY FAILURE; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY;

AGED; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84960532929     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0149283     Document Type: Article

References (28)

1. Hu B, Gadegbeku C, Lipkowitz MS, Rostand S, Lewis J, Wright JT, et al. Kidney function can improve in patients with hypertensive CKD. Journal of the American Society of Nephrology: JASN. 2012; 23 (4):706-13. doi: 10.1681/ASN.2011050456 PMID: 22402803; PubMed Central PMCID: PMC3312500.
2. Turin TC, Hemmelgarn BR. Improvement in kidney function: a real occurrence. Journal of the American Society of Nephrology: JASN. 2012; 23(4):575-7. doi: 10.1681/ASN.2012020144 PMID: 22402801; PubMed Central PMCID: PMC3312508.
3. Perkins RM, Bucaloiu ID, Kirchner HL, Ashouian N, Hartle JE, Yahya T. GFR decline and mortality risk among patients with chronic kidney disease. Clinical journal of the American Society of Nephrology: CJASN. 2011; 6(8):1879-86. doi: 10.2215/CJN.00470111 PMID: 21685022; PubMed Central PMCID: PMC3359538.
4. Matsushita K, Selvin E, Bash LD, Franceschini N, Astor BC, Coresh J. Change in estimated GFR associates with coronary heart disease and mortality. Journal of the American Society of Nephrology: JASN. 2009; 20(12):2617-24. doi: 10.1681/ASN.2009010025 PMID: 19892932; PubMed Central PMCID: PMC2794225.
5. Al-Aly Z, Zeringue A, Fu J, Rauchman MI, McDonald JR, El-Achkar TM, et al. Rate of kidney function decline associates with mortality. Journal of the American Society of Nephrology: JASN. 2010; 21 (11):1961-9. doi: 10.1681/ASN.2009121210 PMID: 20947634; PubMed Central PMCID: PMC3014010.
6. Al-Aly Z, Balasubramanian S, McDonald JR, Scherrer JF, O'Hare AM. Greater variability in kidney function is associated with an increased risk of death. Kidney international. 2012; 82(11):1208-14. doi: 10.1038/ki.2012.276 PMID: 22854642.
7. Turin TC, Hemmelgarn BR. Change in kidney function over time and risk for adverse outcomes: is an increasing estimated GFR harmful? Clinical journal of the American Society of Nephrology: CJASN. 2011; 6(8):1805-6. doi: 10.2215/CJN.05950611 PMID: 21784817.
8. Murphy PA, Cowper DC, Seppala G, Stroupe KT, Hynes DM. Veterans Health Administration inpatient and outpatient care data: an overview. Effective clinical practice: ECP. 2002; 5(3 Suppl):E4. PMID: 12166925.
9. Oddone EZ, Eisen S. Veterans Affairs Research and Development: using science to improve health care for veterans. North Carolina medical journal. 2008; 69(1):35-7. PMID: 18429564.
10. VIReC Research User Guide: VHA Medical SAS® Outpatient Datasets FY2006. U.S. Department of Veterans Affairs. VA Information Resource Center: Hines I, September 2007.
11. VIReC Research User Guide: VHA Medical SAS® Inpatient Datasets FY2006. U.S. Department of Veterans Affairs. VA Information Resource Center: Hines I, September 2007.
12. VIReC Research User Guide: Veterans Health Administration Decision Support System Clinical National Data Extracts H, IL, U.S. Department of Veterans Affairs. VA Information Resource Center September 2009.
13. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Annals of internal medicine. 2009; 150(9):604-12. PMID: 19414839; PubMed Central PMCID: PMC2763564.
14. Xie Y, Bowe B, Xian H, Balasubramanian S, Al-Aly Z. Rate of Kidney Function Decline and Risk of Hospitalizations in Stage 3A CKD. Clinical journal of the American Society of Nephrology: CJASN. 2015; 10(11):1946-55. doi: 10.2215/CJN.04480415 PMID: 26350437; PubMed Central PMCID: PMC4633789.
15. Jones BL, Nagin DS, Roeder K. A SAS Procedure Based on Mixture Models for Estimating Developmental Trajectories. Sociological Methods and Research. 2001; Vol. 29(No. 3):374-93.
16. Jones BL, Nagin DS. Advances in group-based trajectory modeling and an SAS procedure for Estimating them. Sociological Methods & Research. 2007; 35:542-71. doi: 10.1177/0049124106292364
17. Dodge HH, Shen C, Ganguli M. Application of the Pattern-Mixture Latent Trajectory Model in an Epidemiological Study with Non-Ignorable Missingness. Journal of data science: JDS. 2008; 6(2):247-59. PMID: 20401339; PubMed Central PMCID: PMC2855203.
18. Little RJ, Wang Y. Pattern-mixture models for multivariate incomplete data with covariates. Biometrics. 1996; 52(1):98-111. PMID: 8934587.
19. O'Hare AM, Batten A, Burrows NR, Pavkov ME, Taylor L, Gupta I, et al. Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2012; 59(4):513-22. doi: 10.1053/j.ajkd.2011.11.044 PMID: 22305760; PubMed Central PMCID: PMC3312937.
20. Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annual review of clinical psychology. 2010; 6:109-38. doi: 10.1146/annurev.clinpsy.121208.131413 PMID: 20192788.
21. Benjamin Bowe YX, Hong Xian, Sumitra Balasubramanian, and Ziyad Al-Aly. Low levels of high density lipoprotein cholesterol increase the risk of incident kidney disease and its progression. Kidney international.
22. Tonelli M, Klarenbach SW, Lloyd AM, James MT, Bello AK, Manns BJ, et al. Higher estimated glomerular filtration rates may be associated with increased risk of adverse outcomes, especially with concomitant proteinuria. Kidney international. 2011; 80(12):1306-14. doi: 10.1038/ki.2011.280 PMID: 21849971.
23. Park M, Yoon E, Lim YH, Kim H, Choi J, Yoon HJ. Renal hyperfiltration as a novel marker of all-cause mortality. Journal of the American Society of Nephrology: JASN. 2015; 26(6):1426-33. doi: 10.1681/ASN.2014010115 PMID: 25343954; PubMed Central PMCID: PMC4446866.
24. Bhandari S. U-shaped effect of eGFR and mortality. Kidney international. 2012; 81(11):1152. doi: 10.1038/ki.2012.49 PMID: 22584600.
25. Hemmelgarn BR, Clement F, Manns BJ, Klarenbach S, James MT, Ravani P, et al. Overview of the Alberta Kidney Disease Network. BMC nephrology. 2009; 10:30. doi: 10.1186/1471-2369-10-30 PMID: 19840369; PubMed Central PMCID: PMC2770500.
26. Turin TC, Coresh J, Tonelli M, Stevens PE, de Jong PE, Farmer CK, et al. Short-term change in kidney function and risk of end-stage renal disease. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association. 2012; 27(10):3835-43. doi: 10.1093/ndt/gfs263 PMID: 22764191.
27. Turin TC, Coresh J, Tonelli M, Stevens PE, de Jong PE, Farmer CK, et al. One-year change in kidney function is associated with an increased mortality risk. American journal of nephrology. 2012; 36(1):41-9. doi: 10.1159/000339289 PMID: 22699706.
28. Turin TC, Coresh J, Tonelli M, Stevens PE, de Jong PE, Farmer CK, et al. Change in the estimated glomerular filtration rate over time and risk of all-cause mortality. Kidney international. 2013; 83(4):684-91. doi: 10.1038/ki.2012.443 PMID: 23344477.